» Articles » PMID: 30157263

Biophysical Validation of Serotonin 5-HT2A and 5-HT2C Receptor Interaction

Overview
Journal PLoS One
Date 2018 Aug 30
PMID 30157263
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The serotonin (5-HT) 5-HT2A receptor (5-HT2AR) and 5-HT2C receptor (5-HT2CR) in the central nervous system are implicated in a range of normal behaviors (e.g., appetite, sleep) and physiological functions (e.g., endocrine secretion) while dysfunctional 5-HT2AR and/or 5-HT2CR are implicated in neuropsychiatric disorders (e.g., addiction, obesity, schizophrenia). Preclinical studies suggest that the 5-HT2AR and 5-HT2CR may act in concert to regulate the neural bases for behavior. Here, we utilize three distinct biophysical and immunocytochemistry-based approaches to identify and study this receptor complex in cultured cells. Employing a split luciferase complementation assay (LCA), we demonstrated that formation of the 5-HT2AR:5-HT2CR complex exists within 50 nm, increases proportionally to the 5-HT2CR:5-HT2AR protein expression ratio, and is specific to the receptor interaction and not due to random complementation of the luciferase fragments. Using a proximity ligation assay (PLA), we found that cells stably expressing both the 5-HT2AR and 5-HT2CR exhibit 5-HT2AR:5-HT2CR heteroreceptor complexes within 40 nm of each other. Lastly, bioluminescence resonance energy transfer (BRET) analyses indicates the formation of a specific and saturable 5-HT2AR:5-HT2CR interaction, suggesting that the 5-HT2AR and 5-HT2CR form a close interaction within 10 nm of each other in intact live cells. The bioengineered receptors generated for the LCA and the BRET exhibit 5-HT-mediated intracellular calcium signaling as seen for the native receptors. Taken together, this study validates a very close 5-HT2AR:5-HT2CR interaction in cultured cells.

Citing Articles

The effect of single nucleotide polymorphisms on depression in combination with coronary diseases: a systematic review and meta-analysis.

Zhang J, Gao L, Yang G, Kong D Front Endocrinol (Lausanne). 2024; 15:1369676.

PMID: 38745947 PMC: 11091366. DOI: 10.3389/fendo.2024.1369676.


Chlorinated Enyne Fatty Acid Amides from a Marine Cyanobacterium: Discovery of Taveuniamides L-M and Pharmacological Characterization of Taveuniamide F as a GPCR Antagonist with CNR1 Selectivity.

Elsadek L, Ellis E, Seabra G, Paul V, Luesch H Mar Drugs. 2024; 22(1).

PMID: 38248654 PMC: 10817531. DOI: 10.3390/md22010028.


μ-opioid receptor agonists and psychedelics: pharmacological opportunities and challenges.

Salinsky L, Merritt C, Zamora J, Giacomini J, Anastasio N, Cunningham K Front Pharmacol. 2023; 14:1239159.

PMID: 37886127 PMC: 10598667. DOI: 10.3389/fphar.2023.1239159.


Effects of (-)-MBP, a novel 5-HT agonist and 5-HT antagonist/inverse agonist on brain activity: A phMRI study on awake mice.

Sathe P, Ramdasi G, Giammatteo K, Beauzile H, Wang S, Zhang H Pharmacol Res Perspect. 2023; 11(5):e01144.

PMID: 37837184 PMC: 10576165. DOI: 10.1002/prp2.1144.


Discovery of Novel Oleamide Analogues as Brain-Penetrant Positive Allosteric Serotonin 5-HT Receptor and Dual 5-HT/5-HT Receptor Modulators.

Chen J, Garcia E, Merritt C, Zamora J, Bolinger A, Pazdrak K J Med Chem. 2023; 66(14):9992-10009.

PMID: 37462530 PMC: 10853020. DOI: 10.1021/acs.jmedchem.3c00908.


References
1.
Pockros L, Pentkowski N, Conway S, Ullman T, Zwick K, Neisewander J . 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen. Synapse. 2012; 66(12):989-1001. PMC: 3476845. DOI: 10.1002/syn.21592. View

2.
Millan M, Marin P, Bockaert J, Mannoury la Cour C . Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions. Trends Pharmacol Sci. 2008; 29(9):454-64. DOI: 10.1016/j.tips.2008.06.007. View

3.
Cunningham K, Anastasio N . Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction. Neuropharmacology. 2013; 76 Pt B:460-78. PMC: 4090081. DOI: 10.1016/j.neuropharm.2013.06.030. View

4.
Berg K, Maayani S, Goldfarb J, Clarke W . Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists. Ann N Y Acad Sci. 1999; 861:104-10. DOI: 10.1111/j.1749-6632.1998.tb10180.x. View

5.
Anastasio N, Stutz S, Fox R, Sears R, Emeson R, DiLeone R . Functional status of the serotonin 5-HT2C receptor (5-HT2CR) drives interlocked phenotypes that precipitate relapse-like behaviors in cocaine dependence. Neuropsychopharmacology. 2013; 39(2):370-82. PMC: 3970795. DOI: 10.1038/npp.2013.199. View